Clinical trial

A Study to Evaluate Safety and Immunogenicity of AERAS-402

NCT01378312

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-02-01

PhasePHASE1

Study timeline

Study start (unknown)2011-02-01Date precision: month

Registry last updated2014-03-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Tuberculosisunresolved

Interventions

AERAS 402BIOLOGICAL

PlaceboBIOLOGICAL

Sponsors & collaborators

Aeraslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01378312 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.